3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
3
Sarcoma
1
Plasma cell
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Renal Cell
4
Neoplasms
3
Virus Diseases
1
Urinary Bladder Neoplasms
1
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Gastrointestinal Cancer Metastatic
1
Carcinoma, Transitional Cell
1
Carcinoma in Situ
1
Breast Neoplasms
1
Adenoviridae Infections
1
Interventions
Cyclophosphamide
8
pembrolizumab
6
Filgrastim
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Nivolumab
4
Flow Cytometry
4
Antilymphocyte Serum
4
Alemtuzumab
4
Tacrolimus
3
Stem Cell Transplantation
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Mycophenolic Acid
3
Melphalan
3
Dexamethasone
3
Carboplatin
3
Biopsy
3
Azacitidine
3
valspodar
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Vorinostat
2
Vincristine
2
Thiotepa
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Interferons
×
Genitourinary
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled